0001209191-20-063358.txt : 20201214
0001209191-20-063358.hdr.sgml : 20201214
20201214200148
ACCESSION NUMBER: 0001209191-20-063358
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201214
FILED AS OF DATE: 20201214
DATE AS OF CHANGE: 20201214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rodino-Klapac Louise
CENTRAL INDEX KEY: 0001836218
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 201387847
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: STE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-12-14
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001836218
Rodino-Klapac Louise
215 FIRST STREET
CAMBRIDGE
MA
0
1
0
0
Chief Scientific Officer
Common Stock
7169
D
Stock Option (right to buy)
76.36
2019-04-30
2028-04-30
Common Stock
28875
D
Stock Option (right to buy)
145.48
2020-03-04
2029-03-04
Common Stock
2748
D
Stock Option (right to buy)
145.48
2020-03-04
2029-03-04
Common Stock
37252
D
Stock Option (right to buy)
114.47
2021-02-28
2030-02-28
Common Stock
873
D
Stock Option (right to buy)
114.47
2021-02-28
2030-02-28
Common Stock
36627
D
Stock Option (right to buy)
114.47
2021-02-28
2030-02-28
Common Stock
25000
D
Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter.
/s/ Louise Rodino-Klapac
2020-12-14